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Purpose: This study investigated the centrosomal protein, 290-KD (CEP290) associated genotype and ocular and extra-
ocular phenotype in 18 patients with Leber congenital amaurosis (LCA).
Methods: Eighteen patients with LCA from 14 families with mutations in the CEP290 gene were identified with
sequencing or with heteroduplex analysis. Ophthalmic examinations were performed on all patients. Scans of the central
nervous system were reassessed in three patients and obtained in two. Renal function was evaluated in all patients.
Ultrasonography of the kidneys was performed in six patients.
Results: Eight patients (from five families) carried the c.2991+1655A>G mutation homozygously. Nine solitary patients
carried this variant combined with a nonsense, frameshift, or splice site mutation on the second allele. One new nonsense
mutation was identified: c.1078C>T. Fourteen patients (from 12 families) had been completely blind from birth or had
light perception. The best-recorded visual acuity was 20/200. Peripheral fundus changes appeared to be progressive with
a relatively preserved posterior pole. Novel ophthalmic features for the CEP290 phenotype were Coats-like exudative
vasculopathy in two patients, a small chorioretinal coloboma in one patient, and well defined, small, atrophic spots at the
level of the retinal pigment epithelium causing a dot-like appearance in five patients. Some CEP290 patients exhibited
systemic abnormalities. We found abnormal proprioception in two patients and mild mental retardation in one. One patient
was infertile due to immobile spermatozoa. No renal abnormalities were detected.
Conclusions: CEP290-associated LCA has a severe, progressive, and clinically identifiable phenotype. Distinct extra-
ocular findings were noted, which may be attributed to ciliary dysfunction.
Leber congenital amaurosis (LCA) represents a group of
clinically and genetically heterogeneous retinal dystrophies
defined by severe visual dysfunction at birth, sensory
nystagmus, a nondetectable electroretinogram (ERG), and an
autosomal recessive inheritance pattern [1,2]. LCA has an
estimated incidence of 1 in 30,000 newborns and a worldwide
prevalence of approximately 200,000 patients [3,4].
Eighteen causative genes for LCA are known (see B-
diseases), and mutations in these genes account for
approximately 70% of all patients with LCA [5,6]. To date,
the most frequently mutated LCA gene is centrosomal protein,
290-KD (CEP290) [7,8], which encodes a protein
ubiquitously expressed in ciliated cells, including rods and
cones [9]. In addition to LCA, mutations in CEP290 can also
lead to Joubert syndrome [10,11], Senior-Loken syndrome
[10], the lethal disorder Meckel-Gruber syndrome [12,13],
and Bardet-Biedl syndrome [14]. These diseases are termed
ciliopathies, which form a group of overlapping phenotypes
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featuring developmental malformation of the brain, cystic
kidney disease or nephronophthisis, and retinal degeneration.
CEP290 mutations account for 6%–22% of non-
syndromic LCA, depending on the population studied [5,7].
The majority of patients with LCA with CEP290 mutations
carry the intronic mutation c.2991+1655A>G (p.Cys998X),
which with lymphoblast RNA analysis was found to introduce
a cryptic exon into the CEP290 mRNA, creating a stop codon
at the 5′ end of the insertion. However, only approximately
50% of the mRNA contained the cryptic exon, rendering this
variant a hypomorphic mutation, which subsequently may
influence the phenotypic outcome [7].
In the initial report on CEP290-associated LCA, we
reported on intrafamilial variability with respect to visual
acuity in four Canadian patients, and the absence of extra-
ocular symptoms, except for seizures in two affected siblings
and abnormal proprioception in one patient [7]. Several
reports on the CEP290-associated phenotype have since been
published. Perrault et al. [8] described the phenotype as LCA
type 1 (cone-rod), characterized by some photo-aversion, high
hyperopia, severely reduced visual acuity (<20/400), and a
salt-and-pepper aspect of the fundus with macular
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degeneration, resulting in a typical retinitis pigmentosa (RP)
appearance by the second decade. Coppieters and coworkers
also observed the CEP290 LCA phenotype as one of a severe
cone-rod dystrophy with progressive peripheral fundus
changes, but with a relatively spared macular region [15].
Pasadhika et al. [16] studied the morphology of CEP290-
related LCA with spectral domain–optical coherence
tomography (SD-OCT). They showed preservation of the
outer nuclear layer (ONL) with a poorly defined
photoreceptor inner/outer segment junction and with a
distorted inner retina in the central macular area. The ocular
phenotype was further expanded by Littink and colleagues,
who reported on two patients with CEP290 mutations with
relatively well preserved visual acuity (VA) and with
detectable scotopic responses on ERG, leading the authors to
diagnose these patients with early-onset severe retinal
dystrophy rather than LCA [17].
Several groups studied associated extra-ocular signs in
patients with LCA with CEP290 mutations. Perrault et al.
[8] observed transitory hypotonia, ataxia, mental retardation,
and autistic behavior in a minority of their patients with
surprising intra-familiar discrepancies. McEwen and
coworkers [9] examined other ciliary-driven sensory
dysfunctions, and discovered olfactory defects in retinal
degeneration 16 (rd16) mice, and subsequently in patients
with LCA with CEP290 mutations [18]. Coppieters et al.
[15] reported on different degrees of kidney disease and
neurologic involvement in patients carrying the same
CEP290 mutations. The researchers hypothesized that the
neurologic phenotype was modified by the presence of
heterozygous Abelson Helper Integration sit 1 (AHI1)
mutations. Papon and colleagues [19] showed ultrastructural
defects in respiratory cilia in nasal biopsies and brushing on
seven patients with LCA with CEP290 mutations.
The goal of this study was to further delineate the ocular
phenotype of CEP290 LCA and to search for other extra-
ocular symptoms in a cohort of Dutch and Canadian patients.
In the current study of 18 patients, we were able to expand the
ophthalmic phenotype of CEP290-related LCA by Coats-like
exudative vasculopathy and chorioretinal coloboma as new
ophthalmic findings.
METHODS
Mutation analysis: DNA was extracted from peripheral blood
leukocytes using a salting-out procedure [20]. Patients were
tested for the c.2991+1655A>G CEP290 mutation with allele-
specific PCR [7] or with the newest version of the LCA
mutation chip (Asper Ophthalmics, Tartu, Estonia). After one
heterozygous allele was identified, all 53 CEP290 coding
exons were analyzed with bi-directional sequencing or
heteroduplex analysis (ABI3730 and ABI3100 Genetic
Analyzers; Applied Biosystems, Inc. [ABI], Foster City, CA)
to identify the second allele. Primer sequences and PCR
conditions were described previously (Appendix 1) [13].
Briefly, PCR amplification consisted of a denaturizing step at
95 °C for 5 min, followed by 35 cycles of amplification (95 °C
for 30 s, X °C for 30 s, 72 °C for 45 s) and a final extension
at 72 °C for 5 min. In two unrelated affected siblings, no blood
samples were drawn at request of the parents; however,
samples were available for the probands of these families.
Patients: Eighteen healthy patients were recruited at The
Rotterdam Eye Hospital and the Montreal Children’s
Hospital. Written informed consent was obtained from the
patients with LCA or their legal representatives before blood
was drawn. The procedures were approved by the Ethics
Committees of the Rotterdam Eye Hospital and McGill
University Health Centre and adhered to the Declaration of
Helsinki. Ten females and 8 males were included in this study
in an age range from 2 to 43 years. Eight patients of six
families (Patients 1, 2, 3, 4, 5, 6, 12, and 14) were part of a
cohort of patients with LCA whose molecular data, but not
clinical data, were described by den Hollander et al. [7]. The
other ten patients were suspected of carrying CEP290
mutations based on their fundus appearance.
After mutations in CEP290 were identified, retrospective
data were studied, and all 18 patients with LCA were
reexamined. A medical history was taken and included
questions about the age of onset of ocular and potential extra-
ocular symptoms. The history also included questions
concerning pregnancy, birth, post-natal period, development,
consanguinity, and family history. Ophthalmologic
examinations included evaluation of the pupillary reaction
and nystagmus, best-corrected visual acuity (BCVA), and
objective refractive error after cycloplegia. The anterior
segments were examined with slit-lamp biomicroscopy, and
funduscopy was performed after pupillary dilation. In all
patients, fundus photography attempts were made. Optical
coherence tomography (OCT) was obtained in four patients
(OCT3 Stratus; Carl Zeiss Meditec, Inc., Dublin, CA, and
Spectralis; Heidelberg Engineering, Heidelberg, Germany).
ERGs were performed according to International Society for
Clinical Electrophysiology of Vision standards [21]. Renal
function was studied with blood sample testing for potassium,
sodium, creatinine levels, and creatinine clearance in all
patients. Renal ultrasounds were performed to evaluate kidney
architecture in six patients.
Signs of Joubert syndrome (e.g., lack of normal
decussation of superior cerebllar peduncular fiber tracts
[molar tooth sign]) were specifically studied in five patients.
In three patients, previously recorded images of the central
nervous system were reevaluated (magnetic resonance
imaging [MRI] for two and computed tomography [CT] for
one), and in two other patients, MRIs were obtained.
RESULTS
Mutation analysis: The results of the molecular analyses are
summarized in Table 1. Fifteen patients were of Dutch descent
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and three of French-Canadian descent. Three sibships were
included from three (Patients 1–3) and two affected
individuals (Patients 8 and 9, 16, and 17). Eight patients (from
five families) carried the c.2991+1655A>G mutation
homozygously. Nine patients were compound heterozygotes
with one c.2991+1655A>G mutation and a nonsense,
frameshift or splice site mutation on the other allele. One new
CEP290 nonsense mutations was identified: c.1078C>T
(p.Arg360X; Patient 15). Patient 12 was from a
consanguineous marriage, but was compound heterozygous.
Consanguinity was five generations ago, and segregation
analysis showed the mother was a heterozygous carrier of the
R1272X mutation and the father of the c.2991+1655A>G
mutation. The genotype of Patients 1 (and his siblings 2 and
3), 4, 5, 6, 12, and 14 and the co-segregation of four of these
families were described by den Hollander et al. [7] as patients
21365, 21393, 20152, 21918, 17971, and 12832, respectively.
Clinical findings: Clinical information is summarized in
Table 2 except for the description of the retinal appearance
which is separately summarized in Table 3.On medical
history, all patients had roving eye movements, or nystagmus
with sluggishly pupillary reactions since early childhood. Eye
poking was present in 17 patients and enophthalmos in seven
patients (Patients 1, 2, 3, 5, 12, 13, and 17). Photophobia was
not recorded as an early symptom in patients with vision. Two
patients (Patients 2 and 15) developed photophobia later in
life. Three patients (Patients 7, 14, and 15) had a clear history
of night blindness.
In seven patients, no light perception was recorded. In
two, there was an indication of light perception in the past
(Patients 4 and 6). Sixteen eyes of nine patients (Patients 1, 2,
7, 8, 9, 13, 14, 15, and 18) perceived light only. In the other
patients, visual acuity varied from detecting hand motion (one
eye of Patient 13) to 20/200 (one eye of Patient 11).
Deterioration of visual acuity was documented in three
patients over periods of 15 years or more (Patients 7, 11, and
15). Mild to high hyperopia (ranging from +2.00 to +12.00
diopters spherical equivalent) was a constant feature in the
majority of the patients (11 patients). One patient showed
myopia (Patient 15), possibly due to her cataract. Six patients
(Patients 6, 9, 10, 12, 16, and 18) had keratoconus. In five, this
was a bilateral finding. In one patient (Patient 6), ophthalmic
examination was not possible due to severe ectatic corneas
with vascular in-growth and bullous changes (Figure 1A). His
lenses were luxated into the vitreous cavity (as seen on
ultrasonography). Posterior subcapsular cataracts were
observed in two patients (Patients 14 and 15) and an anterior
subcapsular cataract in one (Patient 7). Two patients were
pseudophakic (Patient 8 and 9), and one aphakic (Patient 10).
Seventeen patients were available for funduscopy. A
relatively pink optic disc was observed in 13 patients (Patients
1, 2, 3, 4, 8, 9, 10, 11, 12, 13, 16, 17, and 18; Figure 1B and
Figure 2A). In six (Patients 1, 3, 11, 13, 16, and 18), a distinct
yellowish scleral rim was observed (Figure 2A). Two patients
(Patients 1 and 7) had pseudo-papillary edema with
epipapillary fibrosis in one (Patient 7; Figure 3A). Another
patient (Patient 15) displayed a small chorioretinal coloboma
inferior to the optic disc unilaterally (Figure 4). Vessels were
mildly to moderately attenuated in all but one patient whose
vessels were dilated (Patient 13). One patient (Patient 7)
showed vascular sheathing on the optic disc (Figure 3A).
All 17 patients had a preserved posterior pole. The macula
and fovea were recognizable in all patients but without normal
reflexes. The right eye in Patient 18 was the only exception
TABLE 1. CEP290 MUTATIONS IN LEBER CONGENITAL AMAUROSIS PATIENTS.
  Allele 1 Allele 2
Patient number Origin Mutation Effect Mutation Effect
1$ Netherlands c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
2$ Netherlands c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
3$ Netherlands c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
4 Netherlands c.2991+1655A>G p.Cys998X c.265dupA p.Thr89AsnfsX1
5 Netherlands c.2991+1655A>G p.Cys998X c.679_680delGA p.Glu227SerfsX1
6 Netherlands c.2991+1655A>G p.Cys998X c.180+1G>T splice defect
7 Netherlands c.2991+1655A>G p.Cys998X c.5668G>T p.Gly1890X
8§ Canada c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
9§ Canada c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
10 Canada c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
11 Netherlands c.2991+1655A>G p.Cys998X c.5587–1G>C splice defect
12 Netherlands c.2991+1655A>G p.Cys998X c.3814C>T p.Arg1272X
13 Netherlands c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
14 Netherlands c.2991+1655A>G p.Cys998X c.2991+1655A>G p.Cys998X
15 Netherlands c.5587–1G>C splice defect c.1078C>T p.Arg360X
16¶ Netherlands c.2991+1655A>G p.Cys998X c.3175dup p.Ile1059fs
17¶ Netherlands NT  NT  
18 Netherlands c.4661_4663del p.Glu1544del c.1645C>T p.Arg549X
          *: Previously genotyped by den Hollander et al. [7]; $§¶: sibships; NT: not tested on request of parents.
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because it showed a foveal reflex. The macular region was
relatively darker pigmented compared to the surrounding RPE
in three patients (Patients 3, 12, and 16) (Figure 2A). In four
patients (Patients 7, 10, 15, and 18), the macular region
displayed subtle RPE changes. In six patients (Patients 1, 3,
4, 11, 12, and 15), mild wrinkling of the inner limiting
membrane with or without epiretinal fibrosis was noted.
Two patients did not have peripheral RPE changes
(Patient 9 aged 16 and Patient 12 aged 9). In five patients,
including a sibship of three affected (Patients 1, 2, 3, 10, and
13), small atrophic spots at the level of the RPE that imposed
as dot-like changes were noted in the periphery combined with
a granular aspect of the RPE (Figure 2B). Three of these
patients (Patients 2, 3, and 13) also displayed some intra-
retinal pigmentations. A striking greyish white, patchy tapetal
reflex was seen in the (mid-) periphery in three young patients
(Patients 4, 16, and 17; Figure 5A,B). One (Patient 16) had
hypo- and hyper-pigmented areas in the far periphery whereas
her younger brother (Patient 17) did not. In the remaining
patients (Patients 5, 7, 8, 11, 14, 15, and 18) ranging in age
Figure 1. Ophthalmic features of Patient 6. A: External appearance of the right eye at age 43. Note the ectatic white cornea. B: Fundus
photograph of the right eye of the same patient at the age of six months. Note the normal fundus features.
Figure 2. Fundus photographs of the right eye of Patient 3 at age 13. A: Note the pink optic disc with scleral rim, mild attenuation of vessels,
and preservation of the RPE in the posterior pole, with greyish, darker appearance of the macula with subtle wrinkling of the inner limiting
membrane. B: Note the subtle, atrophic, well defined dot-like changes at the level of the RPE and the bone spicules in the periphery.
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from five to 39, RPE atrophy was more pronounced with bone
spicule-like pigmentations.
Two patients (Patients 7 and 13) were treated for Coats-
like exudative vasculopathy. Patient 7 presented with Coats-
like exudative changes in the left eye at the age of 31 and
developed telangiectatic vessels in the inferior quadrants of
the right eye at the age of 38 (Figure 3B). The other patient
(Patient 13) returned a year after her last check-up because of
photopsia and was found to have exudative detachments with
tortuous, dilated vessels in the inferior quadrants of both eyes
at the age of 18.
Goldmann perimetry was performed in two patients
(Patients 7 and 11) and revealed central visual fields of less
than 5° using the largest target (V-4e). ERG responses were
nondetectable in all patients. OCT images revealed normal-
appearing retinal layers in Patient 12 (Figure 6), whereas
thinned photoreceptor and outer nuclear layers were observed
in two patients with deep foveal pits (Patients 7 and 14) and
cyst-like changes in one of them (Patient 7; Figure 3C). These
cysts were not noted on funduscopy. In another patient
(Patient 11), the thickness of the retinal layers seemed normal,
but foveal depression was lacking.
The motor and intellectual development in 16 patients
was reported and documented as normal when compared to
other blind children. None of our patients had a hearing deficit,
polydactyly, or obesity. Olfactory dysfunction was not
reported. Two patients (Patients 4 and 6) had abnormal
proprioception, and one had mild mental retardation. No
abnormalities suggestive of Joubert syndrome were present
on MRI, although minor anomalies were seen in one patient
Figure 3. Fundus photographs and OCT of Patient 7 at age 39. A: Note the pseudopapillary edema, vascular sheathing, preserved RPE in the
posterior pole, subtle RPE changes in the macula, and the pronounced RPE and choriocapillary atrophy with bone spicule-like pigmentations
along the vascular arcade in the right eye. B: Note the exudation in the posterior pole with shallow detachment in the left eye. C: Spectralis
optical coherence tomography (OCT) image of the macular region of the right eye showing cyst-like changes (*) in the outer nuclear layer
with preservation of the inner/outer segment junction under the fovea but absent in the parafoveal region. Note the thinning of the outer nuclear
layer at the center (arrow).
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with normal intelligence (Patient 4). Neuro-imaging in
another four patients (Patients 1, 5, 7, and 12) did not reveal
any abnormalities of the central nervous system.
Electroencephalography abnormalities were recorded in the
past in one patient (Patient 15) for which she received
treatment with antiepileptic drugs.
All patients had normal renal function on laboratory
testing. No signs of cystic kidney disease were detected on
ultrasonography in the patients (Patients 1, 4, 5, 6, 7, and 12)
tested.
Three male patients were of reproductive age. Two did
not have offspring: one had mental retardation (Patient 6), and
the other one (Patient 7) was infertile due to immobile
spermatozoa. Patient 11 had hypofertility but had conceived
offspring naturally.
DISCUSSION
The goal of the current study was to investigate ocular specific
characteristics and extra-ocular features in patients with
CEP290-related LCA.
In our cohort of 18 patients, we found one new nonsense
mutation (Patient 15; c.1078C>T [p.Arg360X]) in CEP290.
The most frequently encountered CEP290 mutation in
patients of European descent with LCA [7,8], the c.
2991+1655A>G mutation, was detected in 22 of 34 alleles (of
14 families) tested. Almost half of the patients carried a
homozygous c.2991+1655A>G mutation. One third of the
patients had this mutation combined with a nonsense,
frameshift, or splice site mutation on the other allele. In only
two patients, the founder mutation was not detected, but the
ocular phenotype of these patients was identical to the other
patients.
Because of the relative large number of patients with
LCA with CEP290 mutations in the present study spread over
different age groups, we were able to study different stages of
the disease. Although there was some inter- and intrafamilial
variability, the patients showed a relatively homogenous
distinctive phenotype. We found frequently occurring
symptoms as in other forms of LCA, such as eye poking,
enophthalmos, nystagmus, sluggish pupillary reflexes,
hyperopia, keratoconus, and juvenile cataracts [22,23]. Visual
acuity in the majority of the patients was either light
perception or no vision at all from birth. In the small group of
patients with visual acuity equal to or more than hand motion,
we were able to record progressive deterioration of visual
acuity in succeeding years. Although we did not perform a
longitudinal study, with retrospective data analysis (including
fundus color photographs), we established an increase in
degenerative changes on funduscopy, from no changes to
small, well defined, atrophic spots at the level of the RPE (dot-
like) to more pronounced RPE atrophy with intraretinal bone
spicule-like pigmentations and a preserved macular region as
in RP. Based on VA loss and progressive retinal changes over
time, we conclude that LCA caused by CEP290 mutations is
a progressive retinal dystrophy.
Figure 4. Fundus photograph of the right
eye of Patient 15 at age 38. Note the mild
pallor of the optic disc, the attenuation
of the vessels, the chorioretinal
coloboma, the retinal pigment
epithelium atrophy (RPE) atrophy, and
the bone spicule-like pigmentations.
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Perrault et al. [8] and Coppieters et al. [15] classified
CEP290 associated LCA as a cone-rod retinal dystrophy.
Whereas no ERG data were available in the first, the latter
mentioned severe cone-rod disease on ERG testing in three
out of 27 patients with LCA and CEP290 mutations. Littink
and colleagues [17] observed two patients with CEP290
mutations, relatively well preserved VA (up to 20/40), and
only detectable rod function and no cone function on ERG.
Although we did not have recordable ERG responses in any
of the patients studied, our clinical data of progressive
peripheral retina changes and a relatively spared macula even
in late stages of the disease suggest that the patients in this
cohort had a progressive rod-cone type of disease rather than
a cone-rod one.
We were able to get spectral domain–optical coherence
tomography (SD-OCT) in four of our patients. Thinning of
the ONL and the photoreceptor layer was found in two. The
other patients displayed normal retinal layers at the macula
(Figure 6); however, the foveal pit was absent in one. Other
OCT studies in LCA CEP290 patients also showed the
presence of all retinal layers [17]. Pasadhika et al. [16] showed
that the photoreceptor inner/outer segment juncture was
poorly defined in the central macula whereas this junction was
invisible in the periphery. A retained ONL was found in the
central macular area of most patients that was more prominent
at younger age. Inner retinal structures were distorted, and
about half of the studied patients had cystlike lesions in the
inner retina, similar to one of our patients (Figure 3C).
Figure 5. Fundus photographs of the right eye (A) and left eye (B) of Patient 16 at age 4. The optic nerve is pink with mild attenuation of the
vessels and a preserved macula. Note the grayish white, patchy, tapetal reflex in the midperiphery.
Figure 6. Spectralis OCT of the right eye of Patient 12 at age 9. Note the intact and normal thickness of all retinal layers.
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Cideciyan et al. [24] performed a retinal micro-anatomic OCT
study and revealed a relatively preserved foveal cone
photoreceptor lamination and detectable subjacent RPE in
patients with LCA and CEP290 mutations, independent of
severity of visual loss. The sparing of cones, however,
decreased with aging, suggesting that CEP290 mutant central
retinas show slowly progressive degeneration of cones.
Cideciyan et al. [24] also found that cone cell death seemed
considerably slower than the loss of rods, suggesting different
roles of CEP290 in the two photoreceptor populations. These
findings all further support our impression that from a
morphological perspective in fact this type of retinal
dystrophy might be a rod-cone disease.
As for the retinal appearance, in three patients we
observed a striking tapetal reflex, consisting of intraretinal
greyish white marbled areas. In the younger siblings, the
tapetal reflex was more pronounced than in the older patient,
suggesting the possibility of a transient phenomenon, which
was also documented by Littink et al. [17]. One of these
patients carried the intron mutation homozygously whereas
the other was a compound heterozygote. Perrault et al. [8]
depicted the same feature in one of their patients carrying the
c.2991+1655A>G mutation homozygously.
The small atrophic spots at the RPE layer and the tapetal
reflex–like changes seem specific to CEP290-associated
LCA, since they have not been described in other forms of
LCA. Another new observation was a distinct yellow scleral
rim and pseudopapillary edema in a subset of patients. A
scleral ring is a relatively common finding in RP [25] and RP-
related disorders but seems suggestive of this specific type of
LCA.
Two of our patients developed bilateral Coats-like
exudative vasculopathy, a rare complication in patients with
RP (1.2%–3.6%) and frequently associated with juvenile RP
caused by Crumbs like 1 gene (CRB1) mutations [26].
However, Coats-like exudative vasculopathy has never been
described in LCA. In a review paper, Kahn et al. [27] referred
to a report on LCA and Coats-like disease. In retrospect, this
report represents a family with early-onset RP. Our finding of
bilateral Coats reaction in two patients (both homozygous for
the c.2991+1655A>G mutation) suggests mutations in
CEP290 might predispose for this type of complication.
Senior-Loken syndrome, which can also be caused by
CEP290 mutations [10], has also been shown to be associated
with Coats-like disease [28].
Another new finding was the chorioretinal coloboma in
one of our patients who did not carry the founder mutation.
The occurrence of a developmental coloboma may be
coincidental but was reported before in a Dutch patient with
Joubert syndrome [29] for whom no molecular data are
available.
Concerning the extra-ocular symptoms, one of our male
patients (Patient 7) was infertile due to immobile
spermatozoa, and one patient was hypofertile, presumably due
to asthenospermia. This finding was reported previously [19]
in a compound heterozygous CEP290 LCA patient. It seems
logical to assume that CEP290 mutations may cause abnormal
sperm tails and velocity. The observation that axonemes of
spermatozoa were abnormal in groups of patients with X-
Linked RP [30] and Usher syndrome [31] was made more than
20 years ago before the identification of ciliary genes, such as
retinitis pigmentosa type 1(RP1), retinitis pigmentosa GTPase
regulator gene (RPGR), retinitis pigmentosa GTPase
regulator-interacting protein (RPGRIP1), and the Usher
syndrome genes [32]. Infertility in mice with overexpression
of RPGR has been reported recently [33]. Since other cilia-
driven problems were proven, such as ultrastructural
respiratory cilia defects and olfactory dysfunction in patients
with CEP290 mutations and heterozygote carriers [19],
further investigation of sperm abnormalities in male patients
and male heterozygotes would be interesting.
Abnormalities of the central nervous system such as the
molar tooth sign in Joubert syndrome were excluded in five
of our patients including two patients with balance difficulties
one of whom had mild mental retardation. These two ataxic
patients had the c.2991+1655A>G mutation combined with a
severe mutation (frame shift or a splice site) on the other allele.
Perrault and coworkers also found mental retardation and/or
autistic disorders in three CEP290-associated LCA families
with homozygous or compound heterozygous frameshift
mutations. One family had the molar tooth sign, whereas
neuro-imaging was not available for the other two families
[8]. No abnormalities suggestive of renal disease were
detected in our cohort, and no renal cysts were found in the
six patients tested.
Altogether, in our study CEP290-LCA seemed to be
associated with a predominantly ocular phenotype. Although,
we did not examine all our patients in depth for other possible
extra-ocular features such as anosmia and respiratory
dysfunction, indicating aberrant ciliary functioning. Patients
homozygous for the hypomorphic c.2991+1655A>G
mutation might have more residual protein than patients with
compound heterozygous mutations, and therefore might
present with a less severe disease [7]. In this cohort of patients,
however, visual acuity was best in patients who were
compound heterozygotes, and extra-ocular features occurred
in homozygous (mental retardation) and in compound
heterozygous patients (ataxia, mental retardation, and
infertility). Therefore, other genetic variants may modify the
phenotype as described by Leitsch et al. [14], who reported
on a Bardet-Biedl syndrome (BBS) patient with homozygous
CEP290 mutations and one heterozygous mutation in another
ciliary BBS gene (Meckel syndrome type 3 [MKS3]).
Recently, Coppieters and colleagues hypothesized the
influence of heterozygous AHI1 mutations on the CEP290
LCA phenotype. Khanna et al. [34] demonstrated that a
polymorphic coding variant in retinitis pigmentosa GTPase
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regulator-interacting protein-1 like (RPGRIP1L) influences
the development of retinal degeneration in individuals with
ciliopathies caused by mutations in other genes. Therefore,
the predictive value of the genotype seems more complicated
than generally assumed and probably depends on the degree
of complex disruptions.
With the recent promising developments in human gene
replacement therapy in LCA caused by RPE65 mutations
[35-37], treatment options for LCA caused by CEP290
mutations may become available in the future. Since this form
of LCA occurs frequently, the accompanying phenotype
should be recognized. We conclude that the LCA phenotype
resulting from CEP290 mutations in a Dutch and French-
Canadian cohort is a severe, slowly progressive form of LCA
with a clinically identifiable ocular phenotype. The phenotype
consists of a relative normal optic disc with scleral ring, mild
or moderate attenuation of the vessels, a relatively preserved
posterior pole, and some mild lobular RPE atrophy without
obvious bone spicules in the periphery that progresses with
aging. New clinical ocular findings were small, atrophic RPE
spots, Coats-like exudative vasculopathy, and chorioretinal
coloboma. A tapetal reflex was observed as a possible
transient phenomenon. New interesting extra-ocular findings
were immotile spermatozoa and ataxia. Extra-ocular findings
in patients with LCA with CEP290 mutations are relatively
frequent and mutation independent.
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Appendix 1. Sequences and PCR conditions of CEP290.
Abbreviations: °C represents degrees celcius; bp
represents base pairs; F represents forward; MgCl2 represents
magnesium; chloride; R represents reverse. To access the
data, click or select the words “Appendix 1.” This will initiate
the download of a compressed (pdf) archive that contains the
file.
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